TNDM - TANDEM DIABETES CARE INC

QQQ $ 621.89 $ 0.90 (0.15 %)

DIA $ 479.67 $ 5.34 (1.13 %)

SPY $ 683.18 $ 2.90 (0.43 %)

TLT $ 89.94 $ 0.01 (0.01 %)

GLD $ 379.81 $ -0.09 (-0.02 %)

Previous Close

$ 16.37

Open

$ 16.75

Bid

$ 16.54 x 100

Ask

$ 18.75 x 100

Day's Range

$ 16.71 - $ 18.40

52 Week Range

$ 9.98 - $ 38.28

Volume

3,312,586

Average Volume

Market Cap

1.11B

Beta (5Y Monthly)

$ 1.33

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-06-2025	09-30-2025	10-Q
2	08-06-2025	06-30-2025	10-Q
3	04-30-2025	03-31-2025	10-Q
4	02-26-2025	01-01-1970	10-K
5	11-06-2024	09-30-2024	10-Q
6	08-01-2024	06-30-2024	10-Q
7	05-02-2024	03-31-2024	10-Q
8	02-21-2024	12-31-2023	10-K
9	11-01-2023	09-30-2023	10-Q
10	08-03-2023	06-30-2023	10-Q
11	05-03-2023	03-31-2023	10-Q
12	02-22-2023	12-31-2022	10-K
13	11-02-2022	09-30-2022	10-Q
14	08-03-2022	06-30-2022	10-Q
15	05-04-2022	03-31-2022	10-Q
16	02-22-2022	12-31-2021	10-K
17	11-03-2021	09-30-2021	10-Q
18	08-04-2021	06-30-2021	10-Q
19	05-05-2021	03-31-2021	10-Q
20	02-24-2021	12-31-2020	10-K
21	11-05-2020	09-30-2020	10-Q
22	07-30-2020	06-30-2020	10-Q
23	04-30-2020	03-31-2020	10-Q
24	02-24-2020	12-31-2019	10-K
25	11-04-2019	09-30-2019	10-Q
26	08-01-2019	06-30-2019	10-Q
27	04-30-2019	03-31-2019	10-Q
28	02-26-2019	12-31-2018	10-K
29	11-01-2018	09-30-2018	10-Q
30	07-30-2018	06-30-2018	10-Q
31	04-26-2018	03-31-2018	10-Q
32	03-01-2018	12-31-2017	10-K
33	10-26-2017	09-30-2017	10-Q
34	07-27-2017	06-30-2017	10-Q
35	04-27-2017	03-31-2017	10-Q
36	03-08-2017	12-31-2016	10-K
37	11-01-2016	09-30-2016	10-Q
38	07-28-2016	06-30-2016	10-Q
39	04-28-2016	03-31-2016	10-Q
40	02-24-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Barclays Maintains Overweight on Tandem Di...
11/10/2025 19:25:55

Barclays analyst Matt Miksic maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Overweight and raises the price target from...

Morgan Stanley Maintains Equal-Weight on T...
11/10/2025 18:14:22

Morgan Stanley analyst Patrick Wood maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Equal-Weight and raises the price ta...

Truist Securities Reiterates Hold on Tande...
11/10/2025 17:07:17

Truist Securities analyst Richard Newitter reiterates Tandem Diabetes Care (NASDAQ:TNDM) with a Hold and raises the price ta...

Tandem Mobi App For Android Receives FDA C...
11/10/2025 13:38:32

Wells Fargo Maintains Equal-Weight on Tand...
11/07/2025 18:46:54

Wells Fargo analyst Larry Biegelsen maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Equal-Weight and raises the price ta...

12 Health Care Stocks Moving In Friday's I...
11/07/2025 17:05:53

12 Health Care Stocks Moving In Friday's P...
11/07/2025 12:05:44

Tandem Diabetes Care Affirms FY2025 Sales ...
11/06/2025 21:10:26

Tandem Diabetes Care (NASDAQ:TNDM) affirms FY2025 sales outlook from $1.000 billion to $1.000 billion vs $998.025 million estim...

Tandem Diabetes Care Q3 Adj. EPS $(0.31), ...
11/06/2025 21:09:50

Tandem Diabetes Care (NASDAQ:TNDM) reported quarterly losses of $(0.31) per share which met the analyst consensus estimate. Thi...

Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

Tandem Diabetes Care Achieves ISO/IEC 2700...
11/04/2025 13:35:08

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced it achie...

Tandem Diabetes Care Announces That Its t:...
10/29/2025 12:38:59

Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, announced that the t:slim ...

dexcom-faces-new-reports-of-deaths-linked-to-g7-glucose-monitor

DexCom Faces New Reports Of Deaths Linked ...
10/28/2025 18:04:53

Dexcom faces new FDA reports linking its G7 glucose monitor to patient deaths as lawsuits and regulatory scrutiny intensify.

Stifel Reinstates Hold on Tandem Diabetes ...
10/21/2025 14:15:32

Stifel analyst Jonathan Block reinstates Tandem Diabetes Care (NASDAQ:TNDM) with a Hold and announces $15 price target.

Breaking Down Tandem Diabetes Care: 13 Ana...
10/15/2025 18:01:36

Truist Securities Maintains Hold on Tandem...
10/15/2025 16:06:48

Truist Securities analyst Richard Newitter maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Hold and raises the price tar...

Citigroup Maintains Neutral on Tandem Diab...
10/07/2025 17:51:18

Citigroup analyst Joanne Wuensch maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutral and raises the price target fro...

Canaccord Genuity Maintains Buy on Tandem ...
09/29/2025 14:03:25

Canaccord Genuity analyst William Plovanic maintains Tandem Diabetes Care (NASDAQ: TNDM) with a Buy and maintains $24 price ...

Tandem Diabetes Care's t:slim X2 Insulin P...
09/29/2025 13:24:36

Tandem Diabetes Care, Inc.

Tandem Diabetes Study Finds Automated Insu...
09/16/2025 12:36:14

This sub-analysis is the first study to evaluate AID outcomes for people with type 2 diabetes using the Center for Medicare and...